1
|
Tedla M, Suchankova M, Ahrendt K, Varga L, Frajkova Z, Urban J, Kluckova K, Tedlova E, Profant M, Bucova M. Triggering receptor expressed on myeloid cells 1 and 2 in patients with chronic maxillary sinusitis. ACTA ACUST UNITED AC 2021; 122:391-395. [PMID: 34002612 DOI: 10.4149/10.4149/bll_2021_065] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
PURPOSE Chronic sinusitis can result from variable types of immune-mediated process, whose pathogenesis is not fully understood. Triggering receptors expressed on myeloid cells 1 and 2 (TREM-1, TREM-2) are involved in myeloid cell activation enabling these cells to fine-tune the inflammatory response, which may have an impact on subsequent adaptive immunity and may be the key factor in pathogenesis. The aim of the study was to analyse soluble TREM-1 and TREM-2 molecules in maxillary sinus lavage fluid and compare the defined subgroups selected from patients with chronic sinusitis with/without nasal polyps and allergy (asthma and allergic rhinitis). METHODS The levels of soluble TREM-1 and TREM-2 were measured by Elisa test in a cohort of patients with chronic maxillary sinusitis (n=45). We compared subgroups of patients with nasal polyps (n=33) and allergy (n=25: inclusive of asthma (n=11) and allergic rhinitis (n=14)) with the control group of patients without nasal polyps (n=13), and without allergy (n=21). RESULTS The study did not prove the difference between subgroups with and without nasal polyps. The levels of soluble TREM-1 did not differ significantly between patients with allergy (asthma and allergic rhinitis) and the control group without allergy (p=0.4804). The levels of soluble TREM-2 were significantly higher in patients with allergy (p=0.0028), asthma (p=0.0103) and allergic rhinitis (p=0.0137) as compared with the control group. CONCLUSION Our results suggest the role of TREM-2‑mediated activation of myeloid cells in chronic sinusitis accompanied by allergy, asthma, and allergic rhinitis (Tab. 6, Ref. 25).
Collapse
|
2
|
Geneid A, Nawka T, Schindler A, Oguz H, Chrobok V, Calcinoni O, am Zehnhoff-Dinnesen A, Neumann K, Farahat M, Abou-Elsaad T, Moerman M, Chavez E, Fishman J, Yazaki R, Arnold B, Frajkova Z, Graf S, Pflug C, Drsata J, Desuter G, Samuelsson C, Tedla M, Costello D, Sjögren E, Hess M, Kinnari T, Rubin J. Union of the European Phoniatricians' position statement on the exit strategy of phoniatric and laryngological services: staying safe and getting back to normal after the peak of coronavirus disease 2019 (issued on 25th May 2020). J Laryngol Otol 2020; 134:661-664. [PMID: 32613918 PMCID: PMC7399138 DOI: 10.1017/s002221512000122x] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/09/2020] [Indexed: 12/15/2022]
Abstract
BACKGROUND The following position statement from the Union of the European Phoniatricians, updated on 25th May 2020 (superseding the previous statement issued on 21st April 2020), contains a series of recommendations for phoniatricians and ENT surgeons who provide and/or run voice, swallowing, speech and language, or paediatric audiology services. OBJECTIVES This material specifically aims to inform clinical practices in countries where clinics and operating theatres are reopening for elective work. It endeavours to present a current European view in relation to common procedures, many of which fall under the aegis of aerosol generating procedures. CONCLUSION As evidence continues to build, some of the recommended practices will undoubtedly evolve, but it is hoped that the updated position statement will offer clinicians precepts on safe clinical practice.
Collapse
Affiliation(s)
- A Geneid
- Department of Otorhinolaryngology and Phoniatrics – Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Finland
| | - T Nawka
- Department of Audiology and Phoniatrics, Charité – Universitätmedizin Berlin, Germany
| | - A Schindler
- ‘L Sacco’ Department of Biomedical and Clinical Sciences, University of Milan, Italy
| | - H Oguz
- Private practice, Ankara, Turkey
| | - V Chrobok
- Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Hradec Kralove, Charles University, Faculty of Medicine in Hradec Kralove, Czech Republic
| | - O Calcinoni
- Voice and Music Professionals’ Care Team, Milan, Italy
| | - A am Zehnhoff-Dinnesen
- Clinic of Phoniatrics and Pedaudiology, University Hospital Münster, Westphalian Wilhelm University, Germany
| | - K Neumann
- Clinic of Phoniatrics and Pedaudiology, University Hospital Münster, Westphalian Wilhelm University, Germany
| | - M Farahat
- Department of Otolaryngology, Research Chair of Voice, Swallowing, and Communication Disorders, Head and Neck Surgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia
| | - T Abou-Elsaad
- Phoniatric Unit, ORL Department, Faculty of Medicine, Mansoura University, Egypt
| | - M Moerman
- Private practice, Sint-Martens-Latem, Belgium
| | - E Chavez
- Centro de Foniatría y Audiología, Mexico City, Mexico
| | - J Fishman
- Royal National Throat, Nose and Ear Hospital, University College London Hospitals NHS Foundation Trust, UK
| | - R Yazaki
- Artistic Voice Institute, Oswaldo Cruz German Hospital, São Paulo, Brazil
| | - B Arnold
- Private practice, Munich, Germany
| | - Z Frajkova
- Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital and Comenius University Bratislava, Slovakia
| | - S Graf
- Otorhinolaryngology/ Phoniatrics, Klinikum rechts der Isar, Technical University Munich, Germany
| | - C Pflug
- Department of Voice, Speech and Hearing Disorders, Center for Clinical Neurosciences, University Medical Center Hamburg-Eppendorf, Germany
| | - J Drsata
- Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Hradec Kralove, Charles University, Faculty of Medicine in Hradec Kralove, Czech Republic
| | - G Desuter
- Voice and Swallowing Clinic, ENT Head and Neck Surgery Department, Cliniques Universitaires Saint-Luc, Louvain, Brussels, Belgium
| | - C Samuelsson
- Department of Biomedical and Clinical Sciences, Division of Sensory Organs and Communication, Linköping University, Sweden
| | - M Tedla
- Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital and Comenius University Bratislava, Slovakia
| | - D Costello
- Department of ENT, Wexham Park Hospital, Slough, UK
| | - E Sjögren
- Department of Otorhinolaryngology Head and Neck Surgery, Leiden University Medical Center, The Netherlands
| | - M Hess
- Deutsche Stimmklinik, Hamburg, Germany
| | - T Kinnari
- Department of Otorhinolaryngology and Phoniatrics – Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Finland
| | - J Rubin
- Royal National ENT and Eastman Dental Hospitals Division, University College London Hospital NHS Trust, UK
| |
Collapse
|
3
|
Frajkova Z, Krizekova A, Missikova V, Tedla M. Translation, Cross-Cultural Validation of the Voice Handicap Index (VHI-30) in Slovak Language. J Voice 2020; 36:145.e1-145.e6. [PMID: 32402663 DOI: 10.1016/j.jvoice.2020.04.003] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2020] [Revised: 03/26/2020] [Accepted: 04/01/2020] [Indexed: 10/24/2022]
Abstract
PURPOSE The objective of the study is to verify the psychometric properties of Voice Handicap Index (VHI-30) in Slovak language. METHODS Original VHI-30 has been translated into the Slovak language. Fifty-two dysphonic individuals and 104 individuals of the control group without voice disorders were included in the study. Item to total correlation, internal consistency (Cronbach's alpha coefficient α and split-half coefficient), test-retest reliability (correlation coefficient), and validity of VHI 30 (Kruskal-Wallis test) were analyzed. RESULTS Item analysis proved that questionnaire items have a good to excellent correlation to the total score (0.42-0.87, P < 0.05). Good internal consistency was proved by calculating Cronbach's alpha coefficient (0.88, P < 0.05) and split-half correlation for the Total score in VHI (0.997, P < 0.05). Test-retest reliability was found to be strong (0.86, P < 0.05). Validity results of Slovak VHI suggests that total mean scores of control group were significantly lower than total mean scores of dysphonic groups (structural, neurogenic, inflammatory, functional, and nonspecified). Total mean scores indicated no statistically significant difference between dysphonic groups (P < 0.05). The cut-off value of 21 points was determined by Receiver Operating Characteristics (ROC) analysis. CONCLUSION The results of the study proved that the Slovak VHI-30 is a reliable and valid tool. It is useful for assessing disadvantage related to voice disorders from the patient's perspective.
Collapse
Affiliation(s)
- Zofia Frajkova
- Department of ENT and HNS, Medical Faculty of Comenius University, Bratislava, Slovakia; Department of Communication Disorders, Faculty of Education, Comenius University, Bratislava, Slovakia
| | - Alzbeta Krizekova
- Department of Communication Disorders, Faculty of Education, Comenius University, Bratislava, Slovakia
| | - Viera Missikova
- Department of Communication Disorders, Faculty of Education, Comenius University, Bratislava, Slovakia
| | - Miroslav Tedla
- Department of ENT and HNS, Medical Faculty of Comenius University, Bratislava, Slovakia.
| |
Collapse
|